A recent breakthrough in migraine treatment shows, indirectly, how big DNA studies like DecodeME can help find highly effective drugs for patients. Traditional biological research some years ago identified a pair of proteins as being involved in triggering migraines. This insight recently led to clinical trials of new, high-tech monoclonal antibody drugs that target those…

Read More

Important update: DecodeME will launch a few weeks later than planned. We know how important this study is to you and everyone in the M.E./CFS community, so we need to make sure everything is 100% right before launching for the 27,000+ people already interested in taking part. Data protection is one of the things we…

Read More

The transformation needed for people with the chronic, disabling disease/s Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) is huge.  Sonya Chowdhury, Chief Executive of Action for M.E. and Chair of DecodeMe’s Management Group, writes. For many years, children, adults and their families have faced significant stigma, neglect and disadvantage. This has been further compounded by low levels of funding for biomedical…

Read More